PTC Therapeutics
A science-led, patient-centered biopharmaceutical company focused on discovering, developing and commercializing medicine for patients with rare disease.
Launch date
Employees
Market cap
CAD3.4b
Enterprise valuation
CAD2.5b (Public information from Sep 2024)
Share price
$36.16 PTCT
South Plainfield New Jersey (HQ)
Authorizing premium user...